Intellectual Property, Commercial Law & Contracts, Health Law

Rubin v. General Hospital Corp. (Fed. Cir. 2013)

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 5/8/2013

On March 28, the Federal Circuit in Rubin v. General Hospital Corp. affirmed judgment by the District Court for the District of Massachusetts dismissing the suit brought by Drs. Berish Rubin and Sylvia Anderson against The...more

WLF Submits Comments on Abbott's Citizen Petition on Biosimilars

by Donald Zuhn | McDonnell Boehnen Hulbert & Berghoff LLP on 3/7/2013

Last April, Abbott Laboratories filed a Citizen Petition with the U.S. Food and Drug Administration, asking the agency to refrain from accepting biosimilar applications under the Biologics Price Competition and Innovation Act...more

The Legal Framework on Commercial Franchise of In-home Care Business

by Qin Qu on 12/11/2012

To conclude a little bit on some of the most concerned questions from investors in the franchise regulatory environment, I will, in this article, introduce the legal system in China on commercial franchise, what are the...more

Mandelbaum Salsburg Fall 2012 Newsletter

by Arla Cahill on 10/19/2012

Mandelbaum Salsburg's Fall 2012 Newsletter containing helpful information for businesses and individuals. Table of Contents: Why Every Employer Needs a Social Media Policy A Business’s Obligations Under The Identity...more

Baker & McKenzie: Life Sciences Update - September 2012

by Baker & McKenzie Australia on 9/11/2012

September 2012 edition featuring: - Australia introduces compulsory licences for pharmaceutical products - Raising the Bar – Significant Reform of Patent Laws - E-Health - You'll Feel Better: Swisse...more

SOPA Moves to House Committee with Modifications

by Scott & Scott, LLP on 11/15/2011

Scott & Scott, LLP attorney, Keli Johson, says a copyright owner's remedies in enforcing his or her copyright will be directly impacted if the Stop Online Privacy Act (SOPA) is enacted. Foreign websites hosting copyrighted...more

Newsletter Pharma

by Marta Fusco on 2/1/2011

Case law in pharmaceuticals: trademarks, patents and regulatory issue...more

Harvard Medical School Revises Conflicts of Interest Policy for Faculty Relationships with Industry

by William Fabbri on 9/30/2010

The life science industry has had a long and mutually rewarding relationship with Harvard Medical School (HMS). HMS faculty members have founded life science companies, served as advisors and directors to life science...more

Creative Royalty Structures for Life Science Companies

by William Fabbri on 5/12/2010

In any major license or partnering transaction, rarely is the royalty as simple as a single percentage on all net sales. The royalty provisions will include structures such as tier royalties, sublicense royalties, know-how...more

Joint Ownership: Shortcut to Trouble?

by William Fabbri on 2/17/2010

Life science companies are constantly entering into collaborations or other agreements with third parties in which new intellectual property may be created, whether it is a full-fledged partnership with a large pharmaceutical...more

Patent Opposition in India: Recent Trends

by Rahul Dev on 1/12/2010

Therefore, as may be seen, the two-stage patent opposition process has particularly affected the pharmaceutical industry, as the patent applicants are now vulnerable to multiple pre-grant oppositions filed by competitors, or...more

Importance of Patents for Start-ups, specially in Biotech

by Rahul Dev on 1/8/2010

A patent is one of the ways by which technological innovations are protected. The most ironical fact about a patent is that although it gives monopoly for a number of years, but in order to gain the monopoly, the invention...more

An Unclear Diagnosis

by Fenwick & West LLP on 7/24/2009

What constitutes patentable subject matter? The tension between the broad language of 35 U.S.C. Section 101 and the limitations of its scope by the courts is playing out in the context of patent eligibility of process...more